Date(s) - 09 Sep 2021
New Frontiers of Drug Discovery — From Machine Learning to Physics
Thursday, September 9 at 9:00 am PT, 12:00 pm ET and 17:00 BST
Computational drug discovery is playing an increasing role in rapidly advancing best-in-class drug candidates into the clinic.
In this webinar, panelists Jonah Kallenbach (CEO, Reverie Labs) and Woody Sherman (Chief Computational Scientist, Roivant) will discuss various approaches to machine learning and physics-driven drug design, as well as how they are being applied in real-world organizations.